Eyre DR, Weis MA, Hudson DM, Wu JJ, Kim LS. A novel 3-hydroxyproline (3HYP)-rich motif marks the triple-helical C-terminus of tendon type I collagen. J. Biol. Chem. 2011; 286(10):7732-7736. PubMed
Zhu Y, Wu J-J, Weis MA, Mirza SK, Eyre DR. Type IX Collagen Neo-Deposition in Degenerative Discs of Surgical Patients Whether Genotyped Plus or Minus for COL9 Risk Alleles. Spine 2011. PubMed
Pyott SM, Schwarze U, Christiansen HE, Pepin MG, Leistritz DF, Dineen R, Harris C, Burton BK, Angie B, Kim K, Sussman MD, Weis M, Eyre DR, Russell DW, McCarthy KJ, Steiner RD, Byers PH. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum. Mol. Genet. 2011; 20(8):1595-1609. PubMed
Hudson DM, Weis M, Eyre DR. Insights on the Evolution of Prolyl 3-Hydroxylation Sites from Comparative Analysis of Chicken and Xenopus Fibrillar Collagens. PLoS ONE 2011; 6(5):e19336. PubMed
Fernandes RJ, Farnand AW, Traeger GR, Weis MA, Eyre DR. A Role for Prolyl 3-Hydroxylase 2 in Post-translational Modification of Fibril-forming Collagens. J. Biol. Chem. 2011; 286(35):30662-9. PubMed
Amor IM, Rauch F, Gruenwald K, Weis M, Eyre DR, Roughley P, Glorieux FH, Morello R. Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP. Am. J. Med. Genet. A. 2011; 155A(11): 2685-2870. PubMed
Martinez-Glez V, Valencia M, Caparrós-Martin JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL. Identification of a mutation causing deficient CMP1m/mTLF proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum. Mutat. 2011:343-350.
